Medical Patent News RSS Feed - Medical Patent News

BeyondSpring files two patent applications to expand therapeutic scope of Plinabulin

BeyondSpring files two patent applications to expand therapeutic scope of Plinabulin

BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company’s lead compound, Plinabulin. [More]
MEDITE announces granting of German priority patent for Histology 'Lab-in-one Automation' System

MEDITE announces granting of German priority patent for Histology 'Lab-in-one Automation' System

MEDITE Cancer Diagnostics, Inc., specializing in the development, manufacturing and marketing of superior molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and related diseases announced the recent decision of the German Patent Register to grant MEDITE the German priority patent for its Histology "Lab-in-one Automation" System. [More]
TxCell to receive US patent for Ovasave to treat inflammatory bowel disease

TxCell to receive US patent for Ovasave to treat inflammatory bowel disease

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces that a key patent is to be granted on March 31 2015 by the United States Patent and Trademark Office. [More]

Spherix provides update on September 2014 request for inter parties review by VTech, and Uniden

Spherix Incorporated -- an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update on the September 2014 request for inter parties review by VTech Communications, Inc. and Uniden America Corporation. [More]
M-MDSCs may be effective in treating arthritis in humans

M-MDSCs may be effective in treating arthritis in humans

Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, might be an effective treatment for the disease in humans. [More]
LGTmedical issued U.S. patent for Kenek Core audio waveform technology

LGTmedical issued U.S. patent for Kenek Core audio waveform technology

LionsGate Technologies, Inc., a privately-held medical device company, announced today that the U.S. Patent and Trademark Office has issued a patent for its pulse oximetry technology based on the Kenek Core proprietary audio waveform platform. [More]

Kuros Biosurgery granted U.S. patent for synthetic hydrogel technology

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No. 8,961,947. [More]
USPTO issues Notice of Allowance to Can-Fite BioPharma for psoriasis patent

USPTO issues Notice of Allowance to Can-Fite BioPharma for psoriasis patent

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for CF101 in the treatment of psoriasis. [More]
Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation. [More]
VG Life Sciences issues patent relating to treatment of IBD through CLIP-inducing agent

VG Life Sciences issues patent relating to treatment of IBD through CLIP-inducing agent

VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent. [More]
Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Altos Therapeutics, LLC announced today that the Mexican Institute of Industrial Property has issued Patent Number 323020 titled, "D2 Antagonists, Methods of Synthesis and Methods of Use". The patent broadly and specifically covers the company's dopamine D2/D3 drug candidates, their pharmaceutical compositions, and their use to treat a number of important gastrointestinal conditions in humans, such as gastroparesis. [More]
Study finds difference between results from IHC and quantitative molecular techniques

Study finds difference between results from IHC and quantitative molecular techniques

The cause of type 1 diabetes remains unknown. Several studies using immunohistochemistry (IHC) have independently reported hyperexpression of human leukocyte antigen (HLA) class I on pancreatic islet cells in young patients with recent-onset type 1 diabetes. Investigators have therefore suggested that HLA hyperexpression may be an important first step in the development of type 1 diabetes. [More]
LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

LCS Therapeutics announced today that it has entered into a strategic collaboration with Lucerne Biosciences, LLC to commercialize U.S. Patent No. 8,318,813 entitled "Method of Treating Binge Eating Disorder." [More]
BMC Medical wins patent infringement lawsuit against ResMed

BMC Medical wins patent infringement lawsuit against ResMed

The International Trade Commission (ITC) issued its final decision in the case brought by ResMed (RMD) against BMC Medical. [More]
Patent recognizes peptide that reduces tissue damage

Patent recognizes peptide that reduces tissue damage

A Kansas State University research team has received a patent for its use of a peptide that has been shown to prevent or reduce damage to intestinal tissue. [More]
Elegant Medical to receive patent for groundbreaking Stethos electronic stethoscope

Elegant Medical to receive patent for groundbreaking Stethos electronic stethoscope

Elegant Medical LLC today announced it will receive an issued patent from the US Patent and Trademark Office for its groundbreaking Stethos electronic stethoscope, the most significant advancement to the stethoscope in half a century. [More]
GlySure awarded three U.S. patents for proprietary calibration technique, sensor membrane

GlySure awarded three U.S. patents for proprietary calibration technique, sensor membrane

GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, announced today that it has been awarded three U.S. patents covering the company's core proprietary calibration technique and sensor membrane. [More]
Kansas State University awarded patent for a series of synthetic compounds

Kansas State University awarded patent for a series of synthetic compounds

A patent has been issued for a series of synthetic compounds developed at Kansas State University that have applications for treating cancer and other diseases that affect cell communication. [More]
Study shows how exosomes secreted by tumor cells promote tumor growth

Study shows how exosomes secreted by tumor cells promote tumor growth

Researchers at the Bellvitge Biomedical Research Institute of Bellvitge, the Catalan Institute of Oncology and the University Hospital of Bellvitge have participated in an international study published in the journal Cancer Cell that describes how exosomes secreted by tumor cells contain protein and microRNA molecules capable of transform neighboring cells into tumoral cells promoting tumor growth. [More]
Special issue of Technology and Innovation includes articles from Patents for Humanity winners

Special issue of Technology and Innovation includes articles from Patents for Humanity winners

The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure. [More]
Advertisement
Advertisement